Search Within

Michael Morris

  1. "Jason Lewis"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (10)
  3. Book Section (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (24)
  2. Center for Pancreatic Cancer Research (24)
  3. Department of Medicine (24)
  4. GSK Faculty (24)
  5. Genitourinary Oncology Service (24)
  6. Radiochemistry and Imaging Sciences Service (24)

More Groups

People
  1. Jason Lewis (24)
  2. Serge Lyashchenko (12)
  3. Howard Scher (11)
  4. Neeta Pandit-Taskar (11)
  5. Steven Larson (11)
  6. Joseph O'Donoghue (10)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2019 (1)
  5. 2018 (5)
  6. 2016 (4)

More Years

Publications
  1. Journal of Nuclear Medicine (8)
  2. Journal of Clinical Oncology (7)
  3. Internal Medicine Journal (2)
  4. Clinical Cancer Research (1)
  5. European Journal of Nuclear Medicine and Molecular Imaging (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (8)
  2. American Society of Clinical Oncology (7)
  3. Wiley Blackwell (3)
  4. Springer (2)
  5. American Association for Cancer Research (1)
  6. American Medical Association (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Case study #8: Alpha-therapy with radium-223 dichloride for metastatic castration-resistant prostate cancer
    Book Section

    Pasquini, L.; Morris, M. J.; Bodei, L.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Molecular imaging of neuroendocrine prostate cancer by targeting delta-like ligand 3
    Journal Article

    Korsen, J. A.; Kalidindi, T. M.; Khitrov, S.; Samuels, Z. V.; Chakraborty, G.; Gutierrez, J. A.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Assessment of simplified methods for quantification of (18)F-FDHT uptake in patients with metastatic castration-resistant prostate cancer
    Journal Article

    Kramer, G. M.; Yaqub, M.; Vargas, H. A.; Schuit, R. C.; Windhorst, A. D.; van den Eertwegh, A. J. M.; van der Veldt, A. A. M.; Bergman, A. M.; Burnazi, E. M.; Lewis, J. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Reproducibility and repeatability of semiquantitative (18)F-fluorodihydrotestosterone uptake metrics in castration-resistant prostate cancer metastases: A prospective multicenter study
    Journal Article

    Vargas, H. A.; Kramer, G. M.; Scott, A. M.; Weickhardt, A.; Meier, A. A.; Parada, N.; Beattie, B. J.; Humm, J. L.; Staton, K. D.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • α-emitters for radiotherapy: From basic radiochemistry to clinical studies - Part 2
    Journal Article

    Poty, S.; Francesconi, L. C.; McDevitt, M. R.; Morris, M. J.; Lewis, J. S.
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • α-emitters for radiotherapy: From basic radiochemistry to clinical studies - Part 1
    Journal Article

    Poty, S.; Francesconi, L. C.; McDevitt, M. R.; Morris, M. J.; Lewis, J. S.
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Long-half-life (89)Z-labeled radiotracers can guide percutaneous biopsy within the PET/CT suite without reinjection of radiotracer
    Journal Article

    Cornelis, F. H.; Durack, J. C.; Pandit-Taskar, N.; Ulaner, G. A.; Lewis, J. S.; Morris, M. J.; Solomon, S. B.
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save